Rantidine

Drug Overview

Time taken to compute- 0.015 sec

drug details
nameRanitidine
classificationH2-receptor antagonist
pharmacokinetics
absorptionRapidly absorbed from the GI tract.
distributionDistributed throughout the body; crosses the blood-brain barrier in small amounts.
metabolismMetabolized primarily in the liver, and the primary metabolite is inactive.
excretionExcreted primarily in the urine.
suggested dosage
adults
usual150 mg twice daily
max300 mg/day
notesDosage may vary depending on the specific condition being treated. Always follow the prescribed dosage and consult a doctor for specific guidance. **Important Note:** The safety and availability of Ranitidine are currently under review due to potential N-nitrosodimethylamine (NDMA) contamination in some batches. Do not use any ranitidine product unless specifically approved for use in your region and by your healthcare provider. Consult the most up-to-date product information.
indications
1Peptic ulcer disease
2Gastroesophageal reflux disease (GERD)
3Zollinger-Ellison syndrome
4Hypersecretory conditions
safety in pregnancy
categoryCategory B
detailsLimited data suggests no risk to the fetus during pregnancy. However, consult a doctor regarding use. Consult the most up-to-date medical information for current recommendations.
safety in breastfeeding
detailsRanitidine passes into breast milk in small amounts. While generally considered safe, consult a doctor before breastfeeding. Consult the most up-to-date medical information for current recommendations.
side effects
1Headache
2dizziness
3constipation
4diarrhea
5nausea
6vomiting
7abdominal pain
8rash
9pruritus
10liver function abnormalities
11rarely, severe allergic reactions
12aplastic anemia
13leukopenia
14thrombocytopenia
15Note: Rare cases of N-nitrosodimethylamine (NDMA) have been reported in some batches in the past. Consult up-to-date safety information from regulatory bodies and manufacturers.
alternatives
1Famotidine
2Cimetidine
3esomeprazole
4omeprazole
contraindications
1Known hypersensitivity to ranitidine or other H2-receptor antagonists
2Severe hepatic impairment
3Use with caution in patients with a history of blood disorders.
interactions
1
drugCimetidine
mechanismInhibits ranitidine metabolism
effectMay increase ranitidine levels
managementMonitor closely for adverse effects. Consult the prescribing information for specific guidance.
2
drugKetoconazole
mechanismInhibits ranitidine metabolism
effectMay increase ranitidine levels
managementMonitor closely for adverse effects. Consult the prescribing information for specific guidance.
3
drugCYP450 inhibitors
mechanismPotential inhibition of ranitidine metabolism
effectMay increase ranitidine levels
managementMonitor closely for adverse effects. Consult the prescribing information for specific guidance.
4
drugwarfarin
mechanismPossible interaction (mechanism unclear)
effectPotential increased bleeding risk
managementMonitor closely for bleeding problems. Consult the prescribing information for specific guidance.
warnings and precautions
1Caution in patients with pre-existing liver disease
2Patients should be monitored for signs of hypersensitivity reactions
3Monitor renal function in patients with renal impairment
4Patients should be cautioned to avoid driving or operating machinery if dizziness occurs. Always consult the most up-to-date product information.
additional information
1Information on Ranitidine is constantly evolving. The most up-to-date safety data on N-nitrosodimethylamine (NDMA) contamination should be reviewed from official sources. Consult with your healthcare provider.
2Do not use any ranitidine product not specifically approved for usage by your region.
3Always consult a healthcare professional for appropriate use in your situation. The information provided is not a substitute for professional medical advice.
patient info
age
weight

Check another drug or interactions

Most Frequent Searches

Reference Patient:(25 years,Male, 70KGs) *Not a medical advice

Get in Touch Now!

Contact Us